AU2002300522B2 - Method and Apparatus for Circulatory Valve Repair - Google Patents
Method and Apparatus for Circulatory Valve Repair Download PDFInfo
- Publication number
- AU2002300522B2 AU2002300522B2 AU2002300522A AU2002300522A AU2002300522B2 AU 2002300522 B2 AU2002300522 B2 AU 2002300522B2 AU 2002300522 A AU2002300522 A AU 2002300522A AU 2002300522 A AU2002300522 A AU 2002300522A AU 2002300522 B2 AU2002300522 B2 AU 2002300522B2
- Authority
- AU
- Australia
- Prior art keywords
- valve
- grasper
- closure
- repair
- leaflets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000008439 repair process Effects 0.000 title description 45
- 238000000034 method Methods 0.000 title description 30
- 206010027727 Mitral valve incompetence Diseases 0.000 description 47
- 210000004115 mitral valve Anatomy 0.000 description 32
- 208000029078 coronary artery disease Diseases 0.000 description 12
- 210000003709 heart valve Anatomy 0.000 description 12
- 210000005240 left ventricle Anatomy 0.000 description 11
- 230000002861 ventricular Effects 0.000 description 11
- 210000003540 papillary muscle Anatomy 0.000 description 10
- 230000000302 ischemic effect Effects 0.000 description 8
- 206010007559 Cardiac failure congestive Diseases 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 6
- 210000001765 aortic valve Anatomy 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000002612 cardiopulmonary effect Effects 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 206010002388 Angina unstable Diseases 0.000 description 5
- 208000007814 Unstable Angina Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 201000004332 intermediate coronary syndrome Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000003412 degenerative effect Effects 0.000 description 4
- 210000005246 left atrium Anatomy 0.000 description 4
- 238000004904 shortening Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000004792 Prolene Substances 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000002592 echocardiography Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001105 femoral artery Anatomy 0.000 description 3
- 230000000004 hemodynamic effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 210000000591 tricuspid valve Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 201000002064 aortic valve insufficiency Diseases 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000007675 cardiac surgery Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000003102 pulmonary valve Anatomy 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002073 venous valve Anatomy 0.000 description 2
- 201000003130 ventricular septal defect Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 208000020128 Mitral stenosis Diseases 0.000 description 1
- 206010033698 Papillary muscle rupture Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003698 chordae tendineae Anatomy 0.000 description 1
- 201000002816 chronic venous insufficiency Diseases 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 208000025339 heart septal defect Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004971 interatrial septum Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000006887 mitral valve stenosis Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000010882 preoperative diagnosis Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/0682—Surgical staplers, e.g. containing multiple staples or clamps for applying U-shaped staples or clamps, e.g. without a forming anvil
- A61B17/0686—Surgical staplers, e.g. containing multiple staples or clamps for applying U-shaped staples or clamps, e.g. without a forming anvil having a forming anvil staying below the tissue during stapling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2463—Implants forming part of the valve leaflets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0649—Coils or spirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Description
P/00/011 Regulation 3.2
AUSTRALIA
Patents Act 1990
ORIGINAL
COMPLETE SPECIFICATION STANDARD PATENT Invention title: Method and apparatus for circulatory valve repair The following statement is a full description of this invention, including the best method of performing it known to us: dxbmM0111182526vl 304597805 13.08.2002 METHOD AND APPARATUS FOR CIRCULATORY VALVE REPAIR FIELD OF THE INVENTION The present invention relates generally to the field of circulatory valve repair. More particularly, the present invention relates to the field of the repair of heart valves and specifically for the repair of mitral heart valves, for patients suffering from mitral regurgitation.
BACKGROUND OF THE INVENTION There are four valves in the heart that serve to direct the flow of blood through the two sides of the heart in a forward direction. On the left side, the mitral and aortic valves direct oxygenated blood coming from the lungs, through the left side of the heart, into the aorta for distribution to the body. On the right side, the tricuspid valve, located between the right atrium and the right ventricle, and the pulmonary valve, located between the right ventricle and the pulmonary artery, direct de-oxygenated blood coming from the body, through the right side of the heart, into the pulmonary artery for distribution to the lungs. The anatomy of the heart and the structure and terminology of heart valves are described and illustrated in detail in numerous reference works on anatomy and cardiac surgery, including standard texts such as Surgery of the Chest (Sabiston and Spencer, eds., Saunders Publ., Philadelphia) and Cardiac Surgery by Kirklin and Barrett-Boyes, Pathology and Abnormalities of Heart Valves, incorporated herein by reference.
All four heart valves are passive structures in that they do not themselves expend any energy and do not-perform any active contractile function. They consist of moveable "leaflets" that are designed simply to open and close in response to differential pressures on either side of the valve. The mitral valve has two leaflets and the triscupidvalve has three. The aortic and pulmonary valves are referred to as "semilunar valves" because of the unique appearance of their leaflets, which are most aptly termed "cusps" and are shaped somewhat like a half-moon. The components of the mitral valve assembly include the mitral valve annulus; the anterior leaflet; the posterior leaflet; two papillary muscles which are attached at their bases to the interior surface of the left ventricular wall; and multiple chordae tendineae, which couplep the mitral valve leaflets to the papillary muscles.
The problems that can develop with valves can be classified into two categories: stenosis, in which a valve does not open properly, or insufficiency, or regurgitation, in which a valve does not close properly.
Mitral regurgitation is caused by dysfunction of the mitral subvalvular apparatus or direct injury to the valve leaflets. Multiple etiologies can lead to mitral regurgitation, with myxomatous degeneration of the valve and ischemic heart disease accounting for close to 60% of cases.
Repair of the diseased valve requires major surgery on cardiopulmonary bypass to allow access to the valve.
Consequently, some patients in the early or late stages of the disease are not considered appropriate candidates due to the high risk associated with the operation. Multiple studies have demonstrated that prosthetic replacement of the mitral valve can lead to significant postoperative left ventricular dysfunction and often requires lifelong treatment with anticoagulants. Mitral valve repair, using a posterior annuloplasty ring, has demonstrated improved results with better ventricular recovery. Nevertheless, recent studies performed by the inventors (Umana et al., Surg Forum 1997) have revealed that posterior ring annuloplasty causes changes in ventricular geometry that lead to paradoxical movement of the normal papillary muscles, further deteriorating ventricular performance. In contrast, the "bow-tie" repair in which the anterior and posterior leaflets of the mitral valve are fixed in opposition appears to enhance annular contractility while preserving ventricular architecture.
This has resulted in improved postoperative ventricular function almost uniformly.
The present invention addresses the needs of all patients with mitral regurgitation without mitral stenosis, including those who heretofore may have been excluded due to having only moderate MR or being too sick to be candidates for major surgery.
The present invention finds utility not only for the repair of mitral valves but for all valves of the circulatory system, including aortic valves, tricuspid valves, and venous valves.
Techniques for improving the efficacy of corporeal valves are known. For example, Laufer et al., U.S. Patent No. 5,609,598 describes a valving system for treatment of chronic venous insufficiency. The system has inherent limitations in terms of its effectiveness for the procedure described and its applicability, if any, to other valves, especially cardiac valves.
SUMMARY OF THE INVENTION The present invention is directed to a method and apparatus for use in heart valve repair involving the use of an inserted device or grasper for grabbing and clasping together the anterior and posterior leaflets of the valve, by insertion into the left ventricle through the right chest via a thorascope, through the jugular vein, or through the femoral artery. The grasper will grab both leaflets, preferably after the heart has been stopped or slowed pharmacologically. The correctness of the initial grasp is assessed by, for example, intraoperative echocardiography, to ensure, for example, in the case of the mitral valve, that the mitral regurgitation is resolved. If not, the grasper will be able to "adjust" the leaflets to allow better coaptation or, if needed, re-grab the leaflets in a different location.
Either inherent to the grasper, as an integrally attached component or as a separate device, a fastening device is introduced and a fastener is deployed to securely hold the leaflets in place after the grasper has been released. Theremaining portion of the device, or optionally any separate device, is then removed.
Accessory devices needed for the procedure include instruments for thoracoscopic or percutaneous approaches.
While the preferred method and apparatus described hereinbelow is discussed with reference to its use in connection with mitral valve repair, it is contemplated that the same or substantially similar apparatus and methodology would also be useful in repairing other valves found in the human circulatory systems, particularly other heart valves, such as, for example, venous valves, aortic valves and tricuspid valves, amongst others.
OBJECTS OF THE INVENTION It is an object of the invention to provide a method for the repair of heart valves to increase their efficiency.
It is a further object of the invention to provide for a method for the repair of mitral valves to reduce mitral regurgitation.
It is also an object of the invention to provide for amethod for the repair of the mitral valves which eliminates the need for cardiopulmonary bypass surgery.
It is a further object of the invention to provide for an apparatus for percutaneous insertion into the heart to effect the repair of a heart valve.
It is a yet further object of the invention to provide for the repair of a mitral valve by percutaneous insertion of a grasping and fastening device into the heart to repair a mitral valve and reduce or eliminate mitral regurgitation.
These and other objects of the invention will become apparent to one skilled in the art from the more detailed description given below.
BRIEF DESCRIPTION OF THE DRAWINGS FIGS. 1 to 4 are each a schematic representation of a portion of the human heart showing the mitral valve, the left ventricle and an apparatus of the invention in operation; FIG. 5 is a schematic representation of an embodiment of the distal portion of an apparatus of the invention useful for grasping a mitral valve; FIG. 6 is a schematic representation of an embodiment of a distal portion of an apparatus of the invention showing a configuration of a fastener holder and a fastener clip in the open position; FIG. 7 is a schematic representation of an embodiment of FIG. 6 showing the release and closure of the fastener clip; FIG. 8 is a detailed, partly cross-sectional schematic representation of the distal end of a preferred embodiment of a grasper device according to the invention in the open position; FIG. 9 is a detailed, partly cross-sectional schematicrepresentation of the preferred embodiment of a grasper device according to the invention shown in FIG. 8 in a closed position depicting the translocated adjustable grasper and fastener anvil within the jaws; FIG. 10 is a cross-sectional representation across line 10-10 of the adjustable grasper shown in FIG. 9; FIG. 11 is a detailed schematic representation of a preferred embodiment of the grasper device of the apparatus of the invention in the closed position with the integral closure means shown; FIG. 12 is a detailed schematic representation of the preferred embodiment depicted in FIG. 9 showing the closure means piercing the leaflets of the valve; FIG. 13 is a detailed, partly cross-sectional schematic representation of yet another preferred embodiment of the distal end of a grasper device according to the invention showing the use of a coil closure means; FIGS. 14, 15, and 16 are partly cross-sectional schematic representations of another embodiment of the invention, wherein a self-closing closure is used; FIG. 17 is a schematic representation of the selfsealing closure; FIGS. 18 and 19 are schematic representations of an embodiment of the invention with a three-piece closure; FIG. 20 is a schematic representation of an embodiment of the invention with a three-piece closure; FIGS. 21 and 22 are oblique, schematic representations of a valve leaflet closure useful according to the invention; FIG. 23 is a partial cross-sectional view of the closure shown in FIGS. 21 and 22; FIG. 24 is an oblique, schematic representation of another valve leaflet closure useful according to the invention; FIG. 25 is a partial cross-sectional view of the closure in FIG. 24 in position; FIGS. 26 to 28 are each an oblique, schematic representation of a spiral coil valve leaflet closure useful according to the invention; FIG. 29 is an oblique schematic representation of a Ushaped valve leaflet closure useful according to the invention; and FIG. 30 is a partly cross-sectional view of the closure shown in FIG. 29.
DETAILED DESCRIPTION OF THE INVENTION The invention can perhaps be better appreciated by making reference to the drawings. In FIG. 1 a portion of the human heart is depicted showing a mitral valve 10, a left ventricle 12 and the distal end 14 of a grasper apparatus of the invention 16, which has been inserted through an incision 18 in left ventricle 12. Incision 18 is loosely sutured with sutures 20 to loosely hold distal end 18 and to prevent bleeding.
Mitral valve 10 comprises anterior leaflet or cusp 22 and posterior leaflet or cusp 24, as well as two commissural cusps (not shown). The primary intent of the invention herein is to secure the distal sections 26 and 28 of cusps 22 and 24, respectively, together or substantially adjacent.
As can be seen in FIG. 2, the jaws 30 of distal end 14 are separated and positioned exterior to cusps 22 and 24.
Then, as shown in FIG. 3, jaws 30 are clamped together to cause cusp distal sections 26 and 28 to come together. Once a closure is embedded, such as the loop closure 32 in FIG. 4, jaws 30 are opened slightly so that distal section 14 can be withdrawn.
The distal ends of the grasper means can vary greatly.
It is contemplated that a'variety of grasper means may be employed having differing grasper configurations and elements. For example, it is contemplated that the grasper means could be of the type wherein one side of the grasper is stationary and the other side movable. Alternatively, the grasper means might be of the type wherein both sides are movable in concert. Another alternative arrangement comprises a grasper means having multiple grasper elements to enable one to grasp and hold the leaflets of the valve in multiple locations. It is also contemplated that the grasper elements themselves might comprise one or more suction elements to secure and hold the valve leaflets in place.
Preferably the grasper will have the capacity to adjust the leaflets of, for example, a mitral valve to obtain optimal coaptation.
In addition it is contemplated that the grasper may comprise additional technology to facilitate the operation of the grasper. For example, the grasper may have echo doppler probe or a similar visualization technology that would allow even better localization of the leaflets and confirmation of ideal coaptation.
FIG. 5 depicts the grasper end 36 of a percutaneous apparatus 38 with jaws 40 in the open position. Jaws 40 of grasper end 36 are movably engaged about joint 42 such that the jaws may be easily and freely opened or closed by the operator of the percutaneous apparatus.
Depicted in FIG. 6 is an embodiment of the invention showing one possible configuration of a fastener holder 44 with a fastener clip 46 in place held in the open position for placement over the grasped leaflets of a mitral valve.
The fastener holder 44 and fastener clip 46 may be integral with a grasper end as shown in FIG. 5 or separate from it, in which case it will be necessary to also provide a secondary percutaneous means for use in delivering and manipulating the fastener holder 44 and releasing and fixing the fastener clip 46 in the proper position about the leaves of a mitral valve, once they have been properly grasped by jaws 40 of grasper end 36.
FIG. 7 is a more detailed schematic representation of the fastener holder 44 with its jaws 48 in their open position and fastener clip 46 in place in the open position (dotted line). Also shown is fastener clip 46 in its released, closed position. Fastener clip 46, which may have a closed diameter of from about 3 to 7 mm, preferably about mm, will be comprised of a suitable material such as stainless steel, nitinol, or titanium.
FIG. 8 depicts a detailed, partly cross-sectional schematic representation of a preferred embodiment of the grasper device of the present invention, comprising grasper end 50, movable jaws 52 which are movably engaged about joint 54, in the open position, in proximity to valve leaflets 56.
Each jaw 52 has a protruding grasping surface 58. Howeve'r, the grasping surface 58 of one jaw 52 is operatively and slidably connected to a control member 60 to enable one to properly align valve leaflets 56, prior to fastening.
In FIG. 9 the grasper device of the apparatus of the invention shown in FIG. 8 is in a closed position. Moveable jaws 52 have protruding grasper surfaces 58, which engage valve leaflets 56. Leaflets 56 are translocated to a more 9optimum position for fastening by the action of control member 60 on one of protruding grasping surfaces 58, as shown in FIG. 11. Also, stapler action rod 68 is now operatively connected to stapler control member FIG. 10 is a schematic representation of a cross section of the adjustable grasper depicted in FIG. 9. The jaws comprise grasper surfaces 58, an upper anvil 62 with recess 71, and a lower anvil 64 within which is located a staple type fastener 66 to effect the fastening of valve leaflets.
As shown in FIGS. 9, 11, and 12, lower anvil 64 has at least one slanted surface member 72. When stapler action rod 68 is forced distally against slanted surface member 72, stapler fastener 66 is forced through leaflets 56 into upper anvil 62 to close stapler fastener 66.
In another embodiment of the invention shown in FIG. 13, a grasper 80 comprises jaws 82,84. Jaw 82 is movably connected to rod 86 at pivot point 87, and jaw 84 is movably connected at pivot point 88 to rod 90. Rod 92 is movably connected to jaw 84 at pivot 94. Operation of rods 90 and 92 causes jaws 82 and 84 to open and close on valve leaflets 96.
Axial to grasper 80 is a sheath 98 containing a drive mechanism 100 for rotating coil fastener 102. Coil fastener 102 advances in a spiral mode piercing leaflets 96 in multiple locations as coil 102 is advanced into its final position.
Rods 86, 90, and 92 are each operatively connected to one or more control mechanisms (not shown). Also, distal section jaws 82,84 may be slidable within grasper sheath 81.
Another device 110 of the invention is shown in FIGS. 14 to 16, where jaws 112 are operatively connected to a handle mechanism (not shown). Device 110 comprises a movable sheath 114 that contains a straightened closure fastener 116 that is capable of resuming or forming a circular shape to coapt valve leaflets (not shown). Device 110 has a slidably extruding grasping surface 118 that is operatively connected to the handle mechanism.
Once jaws 112 are closed, the distal tip of sheath 114 is advanced distally to be adjacent grasping surface 118 and its cooperating grasping surface 122. A pusher 124 coerces fastener 116 to advance out of the distal end 126 of sheath 114 to form a circular shape. Fastener 116 in this shape will coapt valve leaflets 120, as can be seen in FIG. 17.
The device 130 of the invention shown in FIGS. 18 and 19 is intended to form a three-piece closure device. Jaws 132 each removably hold a closure member 134 having a grasping surface 136. Located axially with device 130 is a closure crimper 138 that is removably fastened at the distal end 140 of a device rod 142. When jaws 132 grasp valve leaflets 144, closure crimper 138 is advanced distally by device rod 142 to fit over the proximal ends of closure members 134. The closure formed is shown in FIG. While a typical grasper means configuration would normally require the use of at least one control wire to actuate the grasper element(s), it is contemplated that multiple separate control wires could also be effectively employed and manipulated from the proximal end of the system to allow for the precise control of the individual grasper elements.
With regard to the fastening means employed, as noted above it is contemplated that the fastening means may be constituted as a single apparatus operating in concert with the grasper means. Alternatively, the fastening means may be constituted as an entirely separate device which is totally independent of the grasper means. More preferably the -11fastening means will be a separate device which will function using a monorail type system, wherein the fastening means will operate independently of the grasper means, but will ride via a loop over the same guidewire/catheter which houses and guides the grasper means.
While the preferred fastener depicted is in the form of a clip or staple, it is also contemplated that the fasteners employed to secure the leaflets of the valve may be of a variety of different configurations, each of which would function with greater or lesser effectiveness depending upon the operative conditions which prevail. In addition to clips or staples it is also contemplated that the following types of fasteners.may also be effectively employed: coils, sutures, dual button fasteners, cufflink-like fasteners, and the like.
Suitable suture fasteners would include those which might require an appropriate mechanism to automatically suture tissue. Coil fasteners would generally be provided with sharpened ends to allow one to screw these fasteners into place by threading the sharpened end through the tissue of the valve leaflet.
With reference to FIGS. 21 to 23 which depict a sequential representation of the closure of valve leaflets using one preferred closure means, shown in FIG. 22 is a clip type closure 150 being inserted through valve leaflets 152.
FIG. 22 shows the clip type closure 150 in the fastened position. FIG. 23 is a cross-sectional view of the clip type closure 150 depicted in FIG. 23. Each closure 150 as shown in FIG. 21 would have a thickness of from about 0.5 to 1.8 mm, preferably about 1 mm, a width of from about 0.3 to 0.7 cm, preferably about 0.5 cm, and a length of from about 0.6 to 1.4 cm, preferably about 1 cm.
-12- FIGS. 24 and 25 are each a schematic representation of-.
the insertion of another preferred closure means of the invention. A staple-type closure 156 is inserted through valve leaflets 158, and then closed, as shown in FIG. 26.
Closure 156 would preferably have an overall length (including sides) of from about 1 to 4 cm, preferably about 3 cm, an effective diameter of from about 0.1 to 0.5 mm, preferably about 0.3 mm, and an opening of from about 0.5 to 1.3 cm, preferably about 1 cm.
FIGS. 26 to 28 are each a schematic representation of the insertion of yet another preferred closure.. A spiral coil closure 160 can be inserted across valve leaflets 162 in longitudinal, latitudinal, or transverse fashion, by use of, for example, the device shown in FIG. 13. -Coils 160 will preferably have pointed ends and will have external dimensions comprising a length of from about 3 to 7 cm, preferably about 5 cm, and a diameter of from about 1 to 3 mm, preferably about 2 mm.
The overall diameter and/or the differential turns of coil 160 may be uniform or they may vary. For example, the diameter at each end of coil 160 could be the same as, greater than, or less than the diameter of the middle portion of the coil. Similarly, the ratio of the turns of the coil to the length, the pitch, could be consistent or the pitch could be greater or less at each end of the coil. The diameter of the coil wire will preferably be consistent.
Each coil 160 would have a length of from about 3 to 7 cm, preferably about 5 cm, with a diameter of from about 1 to 3 mm, preferably about 2 mm, and a coil wire diameter of from about 0.2 to 0.4 mm. The winding of coil 160 should be from about 5 to 10 turns/cm in an unstressed condition.
In FIGS. 29 and 30 a U-shaped barbed clip-type closure -13- 164 is applied to leaflet 166.
The device and fasteners used according to the invention must be comprised of biocompatible, nonimmunogenic materials.
The grasper is preferably comprised of rigid materials such as titanium, nitinol, stainless steel, or rigid polymeric material such as polyethylene or polyurethane. The clips, staples, coils, etc., are preferably comprised of titanium, nitinol, or stainless steel. In some instances fasteners comprised of molded polymeric material may also be useful.
There are four different approaches which one might take to effect a repair of the mitral heart valve according to the invention: Such a procedure might be undertaken while the patient is on by-pass with an open-chest, either transapically or transatrially.. A median sternotomy is performed and the patient is placed on cardiopulmonary bypass by cannulating the ascending aorta and the right atrium. A purse-string suture is then placed on the apex of the left ventricle and a stab incision performed to insert the instrument which will grasp and attach the mitral valve leaflets. Once adequate repair of the valve is attained, the instrument is removed and the air evacuated from the left ventricle through the apical incision. The ventricle is then repaired using conventional wound closure techniques.
Alternatively, the grasper can be introduced through a similar stab incision performed over the roof of the left atrium. The grasper will cross the valve and then be manipulated to revert to grasp the leaflets from the atrial side and place the suturing device, just as postulated from the transventricular approach. Once adequacy of repair is confirmed, the device is extracted and the atriotomy closed using conventional wound closure techniques.
-14- This procedure can alternatively be performed with thepatient off bypass, through either a left or right thoracotomy or a sternotomy incision. The technique would be similar to that outlined for repair of mitral regurgitation on cardiopulmonary bypass. After opening the chest, the patient is placed on medication (beta-blocker) to slow the heart rate to approximately 40 beats per minute. This allows adequate echocardiographic visualization of the leaflets in order to grasp and attach them.
Third, such a procedure can be undertaken thorascopically. The patient is intubated selectively in order to collapse the left lung, and percutaneous ports are inserted in to the left chest allowing visualization of the apex of the heart or left atrium. Through a separate port, thedevice is introduced into the thoracic cavity and subsequently into the left ventricle through the apex.
Previously, a purse-string or triangular suture had been placed around the tip of the ventricle to control bleeding around the ventricular entry site. Subsequent steps of the repair are identical to those described for patients with an open chest, off bypass.
Should the operation require the patient to be placed on bypass, this can be attained percutaneously from the groin by cannulating the femoral artery and vein. This technique could prove particularly useful in the early stages of development of the technique, since the surgeon would be able to operate on a decompressed heart and slow or cease the heart rate as needed, without hemodynamic compromise.
Lastly, a percutaneous approach to repair of the mitral valve would be possible with this invention by inserting the device either through the femoral artery or jugular vein.
When using the former, the left ventricle is reached by placing the device across the aortic valve. The leaflets will be grasped by turning the tip of the instrument approximately 1600 from the entry angle. As previously stated, the grasper's tips are adjusted to obtain optimal apposition and the suturing device delivered. If a transvenous approach is employed, the left atrium is entered through the interatrial septum and the leaflets are handled as described for the transatrial technique.
To determine the relative efficacy of the method of the invention in effecting the repair of heart valves such as mitral valves a number of procedures were performed on both animal and human test subjects as follows: Animal Testing Six adult sheep underwent ligation of OM2 and OM3 through a left thoracotomy to induce chronic ischemic MR.
After 8 weeks, animals were placed on cardiopulmonary bypass.
Using a posterior approach to the left atrium, a bow-tie repair was performed. A posterior suture annuloplasty (DeVega) served as control. Snares were placed on both repairs to allow alternate tightening during measurements.
Ten 2-mm piezo-electric crystals were sutured around the MV annulus and at the bases and tips of the papillary muscles.
Six crystals were secured to the apex septum and epicardial short axis of the left ventricle for 3dimensional sonomicrometry array localization (3D-SAL) imaging.- 3D-SAL measurements were performed after weaning from cardiopulmonary bypass at baseline and with each type of repair. Echocardiography was used to measure MR, MV area, and fractional shortening.
-16-
C
TABLE 1 MR, mitral valve area, and fractional shortening MR FS MVA (cm 2 Baseline 3.3 0.46 5.4 DeVega 1.4 0.53 3.9 Bow-tie 1.2 0.57 3.3 FS fractional shortening; MVA mitral valve area (planimetry).
P 0.0159 vs. baseline 0.0079 vs. baseline As shown from the results presented in Table 1, MR decreased significantly with both repairs compared with baseline. Post-operative improvements in fractional shortening was greater in the bow-tie group but did not reach statistical significance. MVA, measured by planimetry, decreased more with the bow-tie repair; nevertheless, the resultant areas were still substantial without evidence of a transvalvular gradient. Mitral valve annular contractility area change (maximum area minimum area) /maximum area) by 3D-SAL increased from 19.7% 4.0% at baseline to 21.5% 3.2% after bow-tie repair (P 0.026). Suture annuloplasty decreased annular contractility to 15.7% 3.6% (P 0.0011 vs. baseline, and P 0.0001 vs. bow-tie).
The results obtained suggest that current techniques of mitral valve repair in ischemic MR may further impair left ventricular performance by limiting systolic function of the annulus and base of the heart. The bow-tie repair technique which is the subject of the present invention controls MR and directly addresses subvalvular dysfunction resulting in improved annular and left ventricular function.
Human Testing The charts of eleven patients (five males and six females) undergoing mitral valve repair in conjunction with a central leaflet suture ("bow-tie" repair) were reviewed.
Patients were operated on between August 1996 and April 1997.
Mean age was 68 years (range, 44 to 78). Etiology of mitral regurgitation (MR) was ischemic in nine patients and degenerative in two. Mitral regurgitation was attributed to ischemia if any of the following criteria proposed by Radford 6t al. was met: rupture of a papillary muscle chord or head infarction of the papillary muscle in the absence of leaflet pathology clear history of iew onset or worsening of mitral regurgitation after documented myocardial infarction The diagnosis of MR was established by echocardiography in 10/10 patients, and semiquantitatively graded as severe moderate/severe mild/moderate mild and trace. Left sided cardiac catheterization confirmed the presence of MR in nine patients and the presence of critical coronary artery disease (CAD) invariably involving the circumflex and posterior descending artery territories in all patients with ischemic MR. Preoperative diagnoses and hemodynamics obtained during catheterization are shown in Table 2. All patients were in NYHA class III or IV at the time of surgery.
-18- Table 2. Preoperative diagnosis and hemodynamics.
Patient Diagnosis Age CO PCWP v-wave 1 Unstable angina 59 4.2 30 2 CAD/torn post. chord 78 2.4 6 3 CAD 74 n/a 14 4 CAD/MIx3 64 n/a n/a n/a Unstable angina/MIx2 44 4.0 26 41 6 Ischemic VSD 77 4.0 28 21 7 AI/MR 77 4.5 29 39 8 CAD/APM rupture 67 4.3 27 9 CAD/V-tach arrest 71 4.1 20 28 Degenerative MR 70 3.5 20 21 11 AMI/PPM rupture 67 4.1 33 AI-aortic insufficiency; AMI-acute myocardial infarction; APM-anterior papillary muscle; CAD-coronary artery disease; post-posterior; PPM-posterior papillary muscle; VSD-ventricular septal defect; v-tach-ventricular tachycardia With the patient under anesthesia, the valve is visualized on transesophageal echocardiogram (TEE) and the likely mode of failure determined, with special emphasis on the presence of leaflet prolapse and site and direction of the regurgitant jet. After the heart was stopped, a bulb syringe with cold saline is used to distend the left ventricle and confirm the mode of valve failure. A conventional repair using an annuloplasty right is generally performed and the valve is reinspected with saline injection.
If the leaflet edges do not oppose each other in a concentric circle parallel to the annuloplasty ring, and continued regurgitation is observed, then a "bow-tie" repair is initiated. If the repair is performed from the transventricular or transaortic exposure, a single figure of eight 4-0 prolene suture is placed without screening leaflet S-19eight 4-0 prolene suture is placed without screening leafletcoaptation. Using a 4-0 prolene suture, the anterior leaflet is attached to the corresponding posterior leaflet at the site of malapposition. The figure of 8 suture is placed through each leaflet just as the edge turns down to attach to the primary chordae. This is usually the most cephalad site where the 2 leaflets would touch during systole and creates the largest area of coaptation possible.
At time the suture is very close to a commissure and the result is a narrowing of single valve orifice. More commonly, the suture is closer to the center of the valve and a double orifice valve is created which resembles a "bowtie". After visually confirming that the repair is satisfactory with cold saline injection, the atrium is closed, the patient weaned from CPB, and an intraoperative TEE used to confirm the adequacy of the repair. Standard as well as exercise transthoracic echocardiograms were performed prior to discharge to establish the competency of the "bowtie" repair as well as the absence of a significant gradient across the valve.
Six patients were operated on electively for worsening MR leading to intractable congestive heart failure or unstable angina. Four patients underwent emergent operation *due to acute worsening of MR secondary to ischemic anterior papillarymuscle rupture acute MI with cardiogenic shock requiring intraaortic counterpulsation balloon, severe MR and malignant arrhythmias and acute worsening of chronic degenerative MR One patient had moderate MR in association with critical aortic insufficiency. Mean degree of preoperative MR by echo was 3.5 0.7, with mean ejection fraction (EF) of 42% 17%. Nine patients underwent preoperative cardiac catheterization. Mean pulmonary capillary wedge pressure was 23 mmHg 8 mmHg, with mean atrial v-wave of 39 mmHg 25 mmHg; mean CO as measured by thermodilution technique was 3.9 1/min (range 2.4 to 1/min) (Table Concomitant procedures performed at the time of MR included coronary artery bypass grafting (CABG) in eight patients. Of the two patients with a degenerative etiology of valvular disease, one required aortic valve replacement, whereas the second underwent posterior leaflet quadrangular resection and annuloplasty. Two patients, not included in this series, with end-stage congestive heart failure (CHF) secondary to ventricular dilation had "bow-tie" repairs during partial left ventriculectomy. Nine patients has a posterior ring annuloplasty as primary procedure for treatment of MR (Table One patient required repair of ischemic ventricular'septal defect (VSD) through a ventriculotomy, which made insertion of an annuloplasty ring impractical. This patient's mitral valve was successfully repaired with a "bow-tie" alone. A second patient presented with acute MR secondary to rupture of the anterior head of the ppm. Repair of the papillary muscle was performed using pericardial pledgets. Due to the lack of annular dilatation and persistence of MR a "bow-tie" suture was placed without an annuloplasty ring. Control of MR assessed intraoperatively by direct cold saline injection and TEE was satisfactory in all patients.
The word 'comprising' or forms of the word 'comprising' as used in this description and in the claims do not limit the invention claimed to exclude any variants or additions.
Table 3. Operative indications and concomitant procedures Patient Operative indication Other procedures 1 MR, unstable angina CABG, C-E#28 2 Torn post chord, MR Post quad resection, C-E #32 3 CAD,MR CABG, C-E#32 4 CAD,MR CABG, Unstable angina, MR CABG, C-E#28 6 Ischemic VSD, MR CABG 7 Critical AI, MR AVR, 8 CAD, ALM rupture, MR CABG, C-E#26 9 CAD, MR CABG, C-E#28 MR, CHF 11 PPM rupture, MR CABG, primary PPM repair AVR-aortic valve replacement; C-E Cosgrove ring; CHF congestive heart failure; PPM posterior papillary muscle It will thus be seen that the objects set forth above, among those made apparent from the preceding description, are efficiently attained and, since certain changes may be made in the constructions set forth without departing from the spirit and scope of the invention, it is intended that all matter contained in the above description and shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.
-22- DRAWING COMPONENTS No. Component mitral valve 12 left ventricle 14 distal end of grasper 16 grasper 18 incision suture 22 anterior leaflet or cusp 24 posterior leaflet or cusp 26 anterior cusp distal section 28 posterior cusp distal section jaw 32 closure loop 36 grasper end 38 percutaneous apparatus jaw 42 joint 44 fastener holder 46 fastener clip 48 jaw grasper end 52 jaw 54 joint 56 valve leaflet 58 protruding grasping surface control number 62 upper anvil 64 lower anvil 66 staple type fastener 68 staple action rod 71 recess 72 anvil slanted surface -23- grasper 81 grasper sheath 82 jaw 84 jaw 86 rod 87 pivot point 88 pivot point rod 92 rod 94 pivot 96 valve leaflet 98 sheath 100 drive mechanism 102 coil fastener 110 grasper device 112 jaw 114 sheath 116 fastener 118 grasping surface 120 leaflet 122 cooperating grasping surface 124 pusher 130 grasper device 132 jaw 134 closure member 136 grasping surface 138 closure crimper 140 rod distal end 142 device rod 144 valve leaflet 150 clip-type closure 152 valve leaflet 156 staple-type closure 158 valve leaflet -24- 160 spiral closure 162 valve leaflet 164 barbed-clip closure 166 valve leaflet In this specification, where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was at the priority date, publicly available, known to the public, part of common general knowledge; or known to be relevant to an attempt to solve any problem with which this specification is concerned.
The word 'comprising' and forms of the word 'comprising' as used in this description does not limit the invention claimed to exclude any variants or additions.
Modifications and improvements to the invention will be readily apparent to those skilled in the art. Such modifications and improvements are intended to be within the scope of this invention.
8748918_I.doc
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002300522A AU2002300522B2 (en) | 1997-06-27 | 2002-08-13 | Method and Apparatus for Circulatory Valve Repair |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60051078 | 1997-06-27 | ||
| AU82655/98A AU8265598A (en) | 1997-06-27 | 1998-06-25 | Method and apparatus for circulatory valve repair |
| AU2002300522A AU2002300522B2 (en) | 1997-06-27 | 2002-08-13 | Method and Apparatus for Circulatory Valve Repair |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU82655/98A Division AU8265598A (en) | 1997-06-27 | 1998-06-25 | Method and apparatus for circulatory valve repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002300522A1 AU2002300522A1 (en) | 2003-02-13 |
| AU2002300522B2 true AU2002300522B2 (en) | 2007-01-25 |
Family
ID=38134220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002300522A Expired AU2002300522B2 (en) | 1997-06-27 | 2002-08-13 | Method and Apparatus for Circulatory Valve Repair |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2002300522B2 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014062876A3 (en) * | 2012-10-19 | 2014-06-19 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for heart valve repair |
| US9125653B2 (en) | 2012-08-02 | 2015-09-08 | St. Jude Medical, Cardiology Division, Inc. | Flexible nosecone for percutaneous device |
| US9254141B2 (en) | 2012-08-02 | 2016-02-09 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| WO2016110760A1 (en) * | 2015-01-05 | 2016-07-14 | Strait Access Technologies Holdings (Pty) Ltd | Heart valve leaflet capture device |
| US9498228B2 (en) | 2011-02-01 | 2016-11-22 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| US9610082B2 (en) | 2012-01-25 | 2017-04-04 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| US9642706B2 (en) | 2013-03-11 | 2017-05-09 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US9662205B2 (en) | 2012-08-02 | 2017-05-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| US9883855B2 (en) | 2012-01-25 | 2018-02-06 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US10058348B2 (en) | 2012-02-02 | 2018-08-28 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| US10105219B2 (en) | 2012-08-02 | 2018-10-23 | St. Jude Medical, Cardiology Division, Inc. | Mitral valve leaflet clip |
| RU2708222C2 (en) * | 2015-01-05 | 2019-12-04 | Стрейт Эксесс Текнолоджиз Холдингз (Пти) Лтд | Heart valve leaflet capture device |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4809695A (en) * | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
| US5049153A (en) * | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
| US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
| US5542949A (en) * | 1987-05-14 | 1996-08-06 | Yoon; Inbae | Multifunctional clip applier instrument |
| US5571137A (en) * | 1992-07-02 | 1996-11-05 | Marlow Surgical Technologies, Inc. | Endoscopic instrument system and method |
| US5571215A (en) * | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
-
2002
- 2002-08-13 AU AU2002300522A patent/AU2002300522B2/en not_active Expired
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4809695A (en) * | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
| US5542949A (en) * | 1987-05-14 | 1996-08-06 | Yoon; Inbae | Multifunctional clip applier instrument |
| US5049153A (en) * | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
| US5571137A (en) * | 1992-07-02 | 1996-11-05 | Marlow Surgical Technologies, Inc. | Endoscopic instrument system and method |
| US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
| US5571215A (en) * | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9498228B2 (en) | 2011-02-01 | 2016-11-22 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| US9610082B2 (en) | 2012-01-25 | 2017-04-04 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| US10758215B2 (en) | 2012-01-25 | 2020-09-01 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US10405869B2 (en) | 2012-01-25 | 2019-09-10 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US9883855B2 (en) | 2012-01-25 | 2018-02-06 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US10058348B2 (en) | 2012-02-02 | 2018-08-28 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| US9662205B2 (en) | 2012-08-02 | 2017-05-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| US9254141B2 (en) | 2012-08-02 | 2016-02-09 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
| US10105219B2 (en) | 2012-08-02 | 2018-10-23 | St. Jude Medical, Cardiology Division, Inc. | Mitral valve leaflet clip |
| US9125653B2 (en) | 2012-08-02 | 2015-09-08 | St. Jude Medical, Cardiology Division, Inc. | Flexible nosecone for percutaneous device |
| US10617521B2 (en) | 2012-08-02 | 2020-04-14 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| WO2014062876A3 (en) * | 2012-10-19 | 2014-06-19 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for heart valve repair |
| US9066710B2 (en) | 2012-10-19 | 2015-06-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
| US9642706B2 (en) | 2013-03-11 | 2017-05-09 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| US10631873B2 (en) | 2013-03-11 | 2020-04-28 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
| WO2016110760A1 (en) * | 2015-01-05 | 2016-07-14 | Strait Access Technologies Holdings (Pty) Ltd | Heart valve leaflet capture device |
| RU2708222C2 (en) * | 2015-01-05 | 2019-12-04 | Стрейт Эксесс Текнолоджиз Холдингз (Пти) Лтд | Heart valve leaflet capture device |
| US10779944B2 (en) | 2015-01-05 | 2020-09-22 | Strait Access Technologies Holdings (Pty) Ltd | Heart valve leaflet capture device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9427237B2 (en) | Method and apparatus for circulatory valve repair | |
| US20030120341A1 (en) | Devices and methods of repairing cardiac valves | |
| US20050240202A1 (en) | Devices and methods of repairing cardiac valves | |
| US7635386B1 (en) | Methods and devices for performing cardiac valve repair | |
| US6312447B1 (en) | Devices and methods for percutaneous mitral valve repair | |
| US8172856B2 (en) | Methods and apparatus for atrioventricular valve repair | |
| US20060252984A1 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
| US20090069885A1 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
| AU2002300522B2 (en) | Method and Apparatus for Circulatory Valve Repair | |
| US12496061B2 (en) | Minimally invasive heart valve repair in a beating heart | |
| CN107438409B (en) | Apparatus and method for transcatheter heart valve repair under a trigonectomy technique | |
| MXPA99001953A (en) | Method and apparatus for circulatory valve repair | |
| Bertog et al. | The Transapical Off‐Pump Mitral Valve Repair with the NeoChord Implantation (TOP‐MINI) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |